---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-26-000044"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2026-08-06T11:19:04+00:00"
generated_at: "2026-08-06T11:20:05.647748+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q2 net income jumps to $54M; raises FY 2026 revenue and EBITDA guidance

## Summary
- Q2 net revenues +9.2% (+8.0% constant currency); net income $54M ($0.19 diluted EPS) vs $8M ($0.03) in Q2 2025.
- Adjusted EBITDA +10.0% (+8.7% constant currency); Adjusted EPS $0.26, up 30% per diluted share.
- Raises FY 2026 outlook: net revenue growth 5.25%-6.75%, Adjusted EBITDA growth 5.75%-7.25% on constant currency basis.
- Segment constant currency growth: Sterigenics 7.0%, Nordion 16.7%, Nelson Labs 5.4%; Net leverage ratio 3.0x, liquidity ~$950M.

## SEC filing metadata
- accession: 0001822479-26-000044
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2026-08-06T11:19:04+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/0001822479-26-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/shc-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-26-000044
- JSON: https://secwatch.observer/filing/0001822479-26-000044.json
- Plain text: https://secwatch.observer/filing/0001822479-26-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.